Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;9(4):e003629.
doi: 10.1161/CIRCEP.115.003629.

Clinical Diagnosis of Electrical Versus Anatomic Left Ventricular Hypertrophy: Prognostic and Therapeutic Implications

Aapo L Aro  1 , Sumeet S Chugh  2
Affiliations
Review

Clinical Diagnosis of Electrical Versus Anatomic Left Ventricular Hypertrophy: Prognostic and Therapeutic Implications

Aapo L Aro et al. Circ Arrhythm Electrophysiol. 2016 Apr.
No abstract available

Keywords: death, sudden, cardiac; echocardiography; electrocardiography; hypertrophy, left ventricular; mortality.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None

Figures

Figure 1
Figure 1
Evidence suggesting that anatomic vs electric left ventricular hypertrophy (LVH) is distinct entities that not only can overlap but also have independent effects on outcomes. A (adapted from Sundström et al with permission of the publisher Lippincott Williams & Wilkins. Copyright © 2001), risk of mortality associated with and without ECG LVH (Cornell product criteria, ECG+/ECG−) and echocardiographic LVH (echo+/echo−). B (adapted from Narayanan et al with permission of the publisher Elsevier. Copyright © 2001), the relatively small overlap between echo and ECG LVH among cases that suffered sudden cardiac death. C (adapted from Chrispin et al with permission of the publisher Elsevier. Copyright © 2001), the independent effects of ECG LVH on increased risk of atrial fibrillation (AF) even when adjusted for anatomic LVH.
Figure 1
Figure 1
Evidence suggesting that anatomic vs electric left ventricular hypertrophy (LVH) is distinct entities that not only can overlap but also have independent effects on outcomes. A (adapted from Sundström et al with permission of the publisher Lippincott Williams & Wilkins. Copyright © 2001), risk of mortality associated with and without ECG LVH (Cornell product criteria, ECG+/ECG−) and echocardiographic LVH (echo+/echo−). B (adapted from Narayanan et al with permission of the publisher Elsevier. Copyright © 2001), the relatively small overlap between echo and ECG LVH among cases that suffered sudden cardiac death. C (adapted from Chrispin et al with permission of the publisher Elsevier. Copyright © 2001), the independent effects of ECG LVH on increased risk of atrial fibrillation (AF) even when adjusted for anatomic LVH.
Figure 1
Figure 1
Evidence suggesting that anatomic vs electric left ventricular hypertrophy (LVH) is distinct entities that not only can overlap but also have independent effects on outcomes. A (adapted from Sundström et al with permission of the publisher Lippincott Williams & Wilkins. Copyright © 2001), risk of mortality associated with and without ECG LVH (Cornell product criteria, ECG+/ECG−) and echocardiographic LVH (echo+/echo−). B (adapted from Narayanan et al with permission of the publisher Elsevier. Copyright © 2001), the relatively small overlap between echo and ECG LVH among cases that suffered sudden cardiac death. C (adapted from Chrispin et al with permission of the publisher Elsevier. Copyright © 2001), the independent effects of ECG LVH on increased risk of atrial fibrillation (AF) even when adjusted for anatomic LVH.
Figure 2
Figure 2
Consequences and mechanisms of anatomic vs electrical LVH.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Artham SM, Lavie CJ, Milani RV, Patel DA, Verma A, Ventura HO. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis. 2009;52:153–167. - PubMed
    1. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med. 1970;72:813–822. - PubMed
    1. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med. 1969;71:89–105. - PubMed
    1. Kannel WB, Doyle JT, McNamara PM, Quickenton P, Gordon T. Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation. 1975;51:606–613. - PubMed
    1. Rautaharju PM, Soliman EZ. Electrocardiographic left ventricular hypertrophy and the risk of adverse cardiovascular events: A critical appraisal. J Electrocardiol. 2014;47:649–654. - PubMed

Publication types

MeSH terms

LinkOut - more resources